Belishape 120mg Tablet is a medicine used in the management of obesity associated with type 2 diabetes. It helps the body block the absorption of fats from the small intestines and stomach and treats obesity in diabetic people.
Belishape 120mg Tablet is a medicine used in the management of obesity associated with type 2 diabetes. It helps the body block the absorption of fats from the small intestines and stomach and treats obesity in diabetic people.
Belishape 120mg Tablet may be taken with or without food in the dose and duration as per prescription. It must be swallowed whole. It works best when it is used along with regular physical activity and a healthy diet. It should not be taken for the long term unless your doctor tells you to do so.
There is limited data on the side effects of Belishape 120mg Tablet. Let your doctor know if you experience any symptoms while taking the medicine. They may be able to suggest ways to treat or manage the side effects.
Pregnant and breastfeeding women must take this medicine only with a valid prescription. Inform your doctor before taking the medicine if you have any other medical conditions or are taking any other medications. This medicine should not be considered a long-term treatment unless you are prescribed by your doctor.
Obesity
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Belishape 120mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Belishape 120mg Tablet is a lipase inhibitor that works by blocking the enzymes responsible for breaking down dietary fats in the intestines. This prevents fat from being absorbed into the body and allows it to be excreted through the stools. By reducing fat absorption, Belishape 120mg Tablet helps in weight management, which can improve metabolic control in individuals with obesity, particularly those with type 2 diabetes.
Q: What if you forget to take Belishape Tablet?
A: If you miss a dose of Belishape 120mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Belishape 120mg Tablet should be used along with regular physical activity and a healthy diet.
Take it during or up to 1 hour after each meal.
Skip your dose if you miss a meal or if your meal contains no fat.
It should not be taken for longer than six months. If you have been unable to lose weight after 12 weeks of taking this medicine, you should stop taking it and consult your doctor.
Q. Is Belishape 120mg Tablet a steroid?
No. Belishape 120mg Tablet is not a steroid
Q. How does Belishape 120mg Tablet work?
Belishape 120mg Tablet inhibits the activity of lipase, a lipolytic enzyme secreted by the digestive tract and pancreas, and blocks the absorption of fat from the gut, resulting in reduced body weight.
Limited data available
Alcohol:CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Belishape 120mg Tablet. Please consult your doctor.
Pregnancy:CONSULT YOUR DOCTOR
Information regarding the use of Belishape 120mg Tablet during pregnancy is not available. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Information regarding the use of Belishape 120mg Tablet during breastfeeding is not available. Please consult your doctor.
Driving:CONSULT YOUR DOCTOR
It is not known whether Belishape 120mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney:CONSULT YOUR DOCTOR
There is limited information available on the use of Belishape 120mg Tablet in patients with kidney disease. Please consult your doctor.
Liver:CONSULT YOUR DOCTOR
There is limited information available on the use of Belishape 120mg Tablet in patients with liver disease. Please consult your doctor.
Gras J. Cetilistat for the treatment of obesity. Drugs Today (Barc). 2019;49(12):755-9. [Accessed 05 Apr. 2019] (online) Available from: View
Pharmacy Geoff. Cetilistat. [Accessed 05 Apr. 2019] (online) Available from: View
CDSCO: List of new drugs approved in the year 2021 till date. [Accessed 26 Feb. 2025] (online) Available from: View
Padwal R. Cetilistat, a new lipase inhibitor for the treatment of obesity. Curr Opin Investig Drugs. 2008;9(4):414-21. [Accessed 26 Feb. 2025] (online) Available from: View
Independent Platform: MedbeW.com is an independent aggregator. We are not affiliated with the manufacturer. Brand names are property of their respective owners and used here solely for identification.
Procurement & Availability: We do not store all the products listed on this website. This product will be procured from licensed distributors subject to availability. MedbeW acts as a facilitator to procure authentic medicines for you.
We would like to send you discount and latest offers .
